Linked Life Data

17695429

Source:http://linkedlifedata.com/resource/pubmed/id/17695429

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4C
pubmed:dateCreated
2007-8-15
pubmed:abstractText
The primary objective of this study was to determine the maximum tolerated dose (MTD), the toxicity profile and the recommended dose (RD) for phase II of a combination of S-1 and weekly administration of docetaxel.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0250-7005
pubmed:author
pubmed:issnType
Print
pubmed:volume
27
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2657-65
pubmed:meshHeading
pubmed:articleTitle
Phase I study of combination therapy with S-1 and weekly docetaxel for advanced gastric cancer.
pubmed:affiliation
Department of Medical Oncology, Kinki University School of Medicine, Nara Hospital, Otoda, Ikoma, Nara, Japan.
pubmed:publicationType
Journal Article, Clinical Trial, Phase I